Biaryl analogues of teriflunomide as potent DHODH inhibitors.
Erra, M., Moreno, I., Sanahuja, J., Andres, M., Reinoso, R.F., Lozoya, E., Pizcueta, P., Godessart, N., Castro-Palomino, J.C.(2011) Bioorg Med Chem Lett 21: 7268-7272
- PubMed: 22078215 
- DOI: https://doi.org/10.1016/j.bmcl.2011.10.052
- Primary Citation of Related Structures:  
3U2O - PubMed Abstract: 
The structure-activity relationships of a novel series of biaryl dihydroorotate dehydrogenase (DHODH) inhibitors related to teriflunomide are disclosed. These biaryl derivatives were the result of structure-based design and proved to be potent DHODH inhibitors which in addition showed good antiproliferative activities on peripheral blood mononuclear cells and good efficacies in vivo in the rat adjuvant-induced-arthritis model.
Organizational Affiliation: 
Almirall, R&D Centre, Laureà Miró 408-410, Sant Feliu de Llobregat, 08980 Barcelona, Spain. montse.erra@almirall.com